Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer

Carsten Denkert, Chiara Lambertini, Peter A Fasching, Katherine L Pogue-Geile, Max S Mano, Michael Untch, Norman Wolmark, Chiun-Sheng Huang, Sibylle Loibl, Eleftherios P Mamounas, Charles E Geyer, Peter C Lucas, Thomas Boulet, Chunyan Song, Gail D Lewis, Malgorzata Nowicka, Sanne de Haas, Mark Basik

Clinical Cancer Research, 2023 Apr 14

Abstract link

©2023 The Authors; Published by the American Association for Cancer Research.